Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Oncologist - United States
doi 10.1634/theoncologist.2018-0114
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Publisher
Alphamed Press